CAMBRIDGE, MA--(Marketwired - February 27, 2017) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of an updated edition of its valuable reference, Genetics and Evolution of Infectious Diseases, edited by Michel Tibayrenc. This book is aimed at controlling and preventing neglected and emerging worldwide diseases that are a major cause of global morbidity, disability and mortality. Using an integrated approach, the book discusses the constantly evolving field of infectious diseases and their continued impact on the health of populations, especially in resource-limited areas of the world. At the same time, Elsevier announced five additional immunology, virology and microbiology books.
Genetics and Evolution of Infectious Diseases, Second Edition looks at the worldwide human immunodeficiency virus (HIV) pandemic, increasing antimicrobial resistance, and the emergence of many new bacterial, fungal, parasitic and viral pathogens. With contributions from leading authorities, the book includes developments in the field of infectious disease since it was last published in 2010. It demonstrates how the economic, social and political burden of infectious diseases is most evident in developing countries which must confront the dual burden of death and disability due to infectious and chronic illnesses.
Learn more about infectious disease genomics in this sample chapter.
Michel Tibayrenc, M.D., Ph.D., has worked on the evolution of infectious diseases for more than 35 years. He is a director of research emeritus at the French Institut de Recherche pour le Développement (IRD) Montpellier, France, and the founder and principal organizer of the international congresses MEEGID (molecular epidemiology and evolutionary genetics of infectious diseases). The author of more than 200 international papers, Dr, Tibayrenc has been the head of the unit of research "genetics and evolution of infectious diseases" at the IRD research center for 20 years. With his collaborator, Jenny Telleria, he is the founder and scientific adviser of the Bolivian Society of Human Genetics. Dr. Tibayrenc has won the prize of the Belgian Society of Tropical Medicine (1985), and the medal of the Instituto Oswaldo Cruz, Rio de Janeiro (2000), for his work on Chagas disease. A fellow of the American Association for the Advancement of Science, he is the founder and editor-in-chief of the Elsevier journal, "Infection, Genetics and Evolution."
The six new immunology, virology and microbiology titles are:
- Genetics and Evolution of Infectious Diseases, Second Edition by Michel Tibayrenc
- Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging by M.A. Hayat
- American Trypanosomiasis Chagas Disease: One Hundred Years of Research, Second Edition by Jenny Telleria and Michel Tibayrenc
- The Digestive Involvement in Systemic Autoimmune Diseases, Second Edition by Manuel Ramos-Casals, Munther Khamashta, Pilar Brito-Zeron, Fabiola Atzeni and Joan Rodes
- The Heart in Systemic Autoimmune Diseases, Second Edition by Fabiola Atzeni, Andrea Dorea, Mike Nurmohamed and Paolo Pauletto
- The Innate Immune System: A Compositional and Functional Perspective by Tom Monie
In order to meet content needs in immunology, virology and microbiology, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of immunologists and virologists, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.
Note for Editors
E-book review copies of the new books are available to credentialed journalists upon request. Contact Jelena Baras at firstname.lastname@example.org.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Image Available: http://www.marketwire.com/library/MwGo/2017/2/24/11G131308/Images/Genetics_and_Evolution_of_Infectious_Diseases,_2e_-2a56da852d2cbe3b8971915f7daaa8af.jpg